- Cresco Labs (CRLBF, Financial) reported first quarter revenue of $166 million in 2025.
- The company achieved an operating cash flow of $30 million.
- Despite a net loss of $15 million, Cresco maintained a strong cash position with $162 million on hand.
Cresco Labs Inc. (CRLBF), a leading cannabis company, has announced its financial results for the first quarter ending March 31, 2025. The company reported a revenue of $166 million, reflecting a strategic focus on reducing accounts receivable exposure by limiting sales to high-credit-risk wholesale accounts.
The company's operating cash flow for the quarter stood at $30 million, with a free cash flow of $25 million. This performance underscores Cresco Labs' effective cash management strategies, positioning it strongly for future growth opportunities.
Despite recording a net loss of $15 million, the company remains financially robust, concluding the quarter with $162 million in cash, cash equivalents, and restricted cash. This marks Cresco Labs' highest cash balance in the past three years.
Cresco Labs continues to hold the number one market share position in several billion-dollar markets. The company emphasizes a disciplined approach to capital deployment, focusing on margin expansion and sustainable growth.
CEO Charlie Bachtell commented, "We entered 2025 with the flexibility and financial strength needed to navigate market volatility, complete our debt refinancing, and remain both strategic and patient as we invest thoughtfully for long-term growth."
The company will discuss these results further in a conference call scheduled for June 2, 2025, at 8:30 am Eastern Time. This financial performance reinforces Cresco Labs' commitment to maintaining a strong balance sheet and driving long-term value creation in the cannabis industry.
